X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (14) 14
transplantation (14) 14
hematology (13) 13
bmt (10) 10
hematopoietic stem cells (10) 10
bone marrow (9) 9
oncology (9) 9
bone-marrow-transplantation (8) 8
immunology (8) 8
middle aged (8) 8
adult (7) 7
female (7) 7
hematology, oncology and palliative medicine (7) 7
male (7) 7
aged (6) 6
stem cells (6) 6
versus-host-disease (6) 6
adolescent (5) 5
article (5) 5
cancer (5) 5
clinical trials (5) 5
quality of life (5) 5
analysis (4) 4
hematopoietic stem cell transplantation (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
impact (4) 4
medical research (4) 4
medicine, experimental (4) 4
survival (4) 4
transplantation conditioning (4) 4
transplantation, homologous (4) 4
transplants & implants (4) 4
treatment outcome (4) 4
acute myeloid-leukemia (3) 3
adults (3) 3
blood (3) 3
bone marrow transplantation (3) 3
bone-marrow (3) 3
cancer-patients (3) 3
disease-free survival (3) 3
graft vs host disease - prevention & control (3) 3
hematologic neoplasms - therapy (3) 3
outcomes (3) 3
patients (3) 3
prognosis (3) 3
prospective studies (3) 3
research (3) 3
survival rate (3) 3
therapy (3) 3
unrelated donors (3) 3
young adult (3) 3
allografts (2) 2
bone marrow transplantation - methods (2) 2
care and treatment (2) 2
caregivers (2) 2
child (2) 2
children (2) 2
chronic disease (2) 2
clinical trials as topic (2) 2
cyclophosphamide (2) 2
cyclosporine (2) 2
depression (2) 2
dosage and administration (2) 2
fact-bmt (2) 2
follow-up studies (2) 2
functional assessment (2) 2
graft versus host reaction (2) 2
graft vs host disease - drug therapy (2) 2
graft vs host disease - etiology (2) 2
gvhd (2) 2
health aspects (2) 2
hematologic malignancies (2) 2
hematologic neoplasms - mortality (2) 2
hemic and lymphatic diseases (2) 2
hemopoiesis (2) 2
high-risk (2) 2
hla-haploidentical bmt (2) 2
immune system diseases (2) 2
immunosuppressive agents - therapeutic use (2) 2
leukemia, myeloid, acute - therapy (2) 2
medical colleges (2) 2
patient outcomes (2) 2
psychological distress (2) 2
randomized-trial (2) 2
risk (2) 2
risk factors (2) 2
sickle cell disease (2) 2
surgical procedures, operative (2) 2
term-follow-up (2) 2
time factors (2) 2
unrelated bmt (2) 2
1st international-conference (1) 1
36-item short form health survey (1) 1
36‐item short form health survey (1) 1
abo-incompatible bmt (1) 1
abridged index medicus (1) 1
acute disease (1) 1
acute lymphoblastic-leukemia (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Haematology, ISSN 2352-3026, 03/2019, Volume 6, Issue 3, pp. e132 - e143
Journal Article
Cancer, ISSN 0008-543X, 12/2017, Volume 123, Issue 23, pp. 4687 - 4700
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) cures many patients, but often with the risk of late effects and impaired quality of life. The... 
36‐Item Short Form Health Survey (SF‐36) | Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT‐BMT) | patient‐reported outcomes | survival | transplantation | patient-reported outcomes | 36-Item Short Form Health Survey (SF-36) | Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT-BMT) | PREDICTS | HEMATOPOIETIC-CELL TRANSPLANTATION | FEASIBILITY | BMT CTN | LONG-TERM HEALTH | CHILDREN | Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) | ONCOLOGY | MALIGNANCIES | QUALITY-OF-LIFE | Hematologic Neoplasms - therapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Child, Preschool | Hematopoietic Stem Cell Transplantation | Male | Data Collection - methods | Transplantation, Homologous | Feasibility Studies | Young Adult | Adolescent | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Transplantation Conditioning | Neoplasm Staging | Child | Patient Reported Outcome Measures | Treatment outcome | Usage | Analysis | Transplantation | Hematopoietic stem cells | Data entry | Quality of life | Transplants & implants | Syngeneic grafts | Feasibility studies | Bone marrow transplantation | Cures | Patients | Survival | Hemopoiesis | Confidence intervals | Demographics | Bone cancer | Bone marrow | Data collection | Collection | Quartiles | Adults | Children | Specific retention | Cancer | FACT-BMT | Patient-Reported Outcomes | SF-36
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1747 - 1757
Journal Article
BONE MARROW TRANSPLANTATION, ISSN 0268-3369, 08/2019, Volume 54, Issue Suppl 2, pp. 769 - 774
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2009, Volume 35, Issue 8, pp. 653 - 661
Summary Rituximab is a chimeric monoclonal antibody directed against CD20, a B-cell antigen expressed on B-cell lymphoma. It is widely used as single agent for... 
Hematology, Oncology and Palliative Medicine | BMT | Rituximab manuscript | GVHD | B-cells in transplantation | B-cells APC | SYSTEMIC-LUPUS-ERYTHEMATOSUS | BONE-MARROW-TRANSPLANTATION | INTERLEUKIN-1 RECEPTOR ANTAGONIST | AUTOIMMUNE HEMOLYTIC-ANEMIA | VERSUS-HOST-DISEASE | IDIOPATHIC THROMBOCYTOPENIC PURPURA | ANTI-CD20 MONOCLONAL-ANTIBODY | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | ONCOLOGY | MINOR HISTOCOMPATIBILITY ANTIGENS | NON-HODGKINS-LYMPHOMA | Graft vs Host Disease - complications | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Graft vs Host Disease - immunology | Transplantation, Homologous | Lymphoma, B-Cell - immunology | Antibodies, Monoclonal - immunology | Chemokines - immunology | Cytokines - immunology | Lymphoma, B-Cell - drug therapy | Acute Disease | Antibodies, Monoclonal, Murine-Derived | Antineoplastic Agents - immunology | Thrombocytopenia - immunology | Hematopoietic Stem Cell Transplantation | Rituximab | Antineoplastic Combined Chemotherapy Protocols - immunology | B-Lymphocytes - drug effects | B-Lymphocytes - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Graft vs Host Disease - prevention & control | T-Lymphocytes - immunology | Transplantation Conditioning | Chronic Disease | Medical colleges | Care and treatment | Stem cells | Bone marrow | Transplantation | Lymphomas | T cells | Hematopoietic stem cells | Cancer
Journal Article
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, ISSN 1521-6926, 12/2019, Volume 32, Issue 4, p. 101112
Close HLA matching of donors and recipients has been the dogma for successful allogeneic blood or marrow transplantation (BMT), to limit the complications of... 
TRIALS | Allogeneic transplantation | BONE-MARROW-TRANSPLANTATION | ADULTS | BMT | Unlearning | OUTCOMES | Haploidentical | HEMATOLOGY | VERSUS-HOST-DISEASE | Post-transplant cyclophosphamide | BLOOD
Journal Article